Alzamend Neuro Capital Raise of $10M
Alzamend Neuro entered into an Amended and Restated Securities Purchase Agreement with Ault Lending, LLC to sell $10 million in Series D convertible preferred stock. This amends a previous agreement for $25 million, with $7.5 million already raised in an initial tranche and an additional $2.5 million committed for a second tranche closing.
- Value
- $10M
- Counterparty
- Ault Lending, LLC